JapanStake
Pharmaceutical · Fiscal year end Mar 31

YUKI GOSEI KOGYO CO.,LTD.

4531

有機合成薬品工業株式会社

FIGI BBG000BCXL524531.T4531 JPCorp. no. 9010001059621

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-13

For the first half of the fiscal year to 2026-03: Revenue ¥7.8 billion (+8.7% YoY), Ordinary income ¥0.2 billion (-48.1% YoY), Net income ¥0.2 billion (-54.9% YoY).

This periodYear on year
Revenue¥7.8bn+8.7%
Ordinary profit¥227m-48.1%
Net profit to owners¥165m-54.9%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4531/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2026-03-31
Revenue
¥15.4bn
Net income
¥313m
ROE
2.4%
Equity ratio
52.4%
Dividend / share
¥10
Employees
296
Revenue · ¥bn
FY2022: ¥12.4bn 12.4 FY2022FY2023: ¥12.8bn 12.8 FY2023FY2024: ¥12.9bn 12.9 FY2024FY2025: ¥15.1bn 15.1 FY2025FY2026: ¥15.4bn 15.4 FY2026
Net income · ¥m
FY2022: ¥248m 248 FY2022FY2023: ¥556m 556 FY2023FY2024: ¥776m 776 FY2024FY2025: ¥896m 896 FY2025FY2026: ¥313m 313 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥15.4bn¥0.3bn¥25.7bn¥13.5bn2.4%¥14.51¥2.8bn
2025-03-31¥15.1bn¥0.9bn¥26.9bn¥13.1bn7.0%¥41.4¥2.1bn
2024-03-31¥12.9bn¥0.8bn¥24.4bn¥12.4bn6.5%¥35.57¥0.4bn
2023-03-31¥12.8bn¥0.6bn¥22.1bn¥11.5bn5.0%¥25.51¥0.7bn
2022-03-31¥12.4bn¥0.2bn¥21.2bn¥11.0bn2.3%¥11.37¥1.8bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %2.3612.3
Ordinary margin0.019617.1
Equity ratio, %52.444.8
Revenue growth0.021235
Net income growth-0.650710.5
Operating cash flow / assets0.110578.1
Policy-uncertainty measure2.27 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Politics & geopolitics 2
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 30.2% held by other listed companies.

Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥6.5bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥33m, 1.1% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4531/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-23: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-24 · 剰余金処分の件 · passed. /v1/companies/4531/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥284¥294¥303 2023-12-062024-07-16 2024-07-16 · sold 671,300 @ ¥303 · 住友化学株式会社2023-12-06 · sold 223,700 @ ¥284 · 住友化学株式会社
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
住友化学株式会社2023-12-06 – 2024-07-16-895,000−4.07pt¥298.25¥284–303

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4531/trades.

5% filings

Large shareholding reports on 4531
FiledFilerStakeChangeStated purpose
2025-02-18Mitsubishi UFJ Financial Group, Inc.4.81%−0.33ptstrategic holding
2024-07-29Mitsubishi UFJ Financial Group, Inc.5.14%−0.50ptstrategic holding
2024-07-17SUMITOMO CHEMICAL COMPANY, LIMITED2.92%−3.38ptbusiness alliance
2023-12-13SUMITOMO CHEMICAL COMPANY, LIMITED6.30%−1.02ptbusiness alliance
2023-12-08SUMITOMO CHEMICAL COMPANY, LIMITED6.30%−1.02ptbusiness alliance
2023-10-16Mitsubishi UFJ Financial Group, Inc.5.64%−1.00ptstrategic holding
2023-06-05SUMITOMO CHEMICAL COMPANY, LIMITED7.32%0.00ptbusiness alliance
2022-09-20Mitsubishi UFJ Financial Group, Inc.6.64%−1.96ptstrategic holding
2022-07-04Mitsubishi UFJ Financial Group, Inc.8.60%−1.00ptstrategic holding

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
9 issues
Book value
¥2.3bn
Sold in the year
¥113m 4 issues
Bought in the year
— — issues
Mutual, both reports
5
Held by listed cos.
7
HoldsBook valueShares vs. prior yearMutual
ZERIA PHARMCEUTICAL CO., LTD. 4559¥597m0.0%both reports
SUMITOMO CORPORATION 8053¥421m0.0%stated
ASKA Pharmaceutical Holdings CO., Ltd. 4886¥354m0.0%both reports
Mitsubishi UFJ Financial Group, Inc. 8306¥275m-6.6%stated
OSAKA SODA CO.,LTD. 4046¥203m0.0%stated
KUREHA CORPORATION 4023¥183m0.0%both reports
NIPRO CORPORATION 8086¥155m0.0%both reports
Mebuki Financial Group,Inc. 7167¥125m-6.6%stated
Tokyo Kiraboshi Financial Group, Inc. 7173¥33m-6.2%both reports
久光製薬株式会社 4530—sold allstated

Held by: NIPRO CORPORATION 8086, Hodogaya Chemical Co.,Ltd. 4112, NAGASE & CO., LTD. 8012, ZERIA PHARMCEUTICAL CO., LTD. 4559, ASKA Pharmaceutical Holdings CO., Ltd. 4886, KUREHA CORPORATION 4023, Tokyo Kiraboshi Financial Group, Inc. 7173

Purposes, all holdings and mutual flags via /v1/companies/4531/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
ニプロ株式会社3,296,00015.25%
長瀬産業株式会社1,098,0005.08%
保土谷化学工業株式会社1,098,0005.08%
大鵬薬品工業株式会社671,0003.11%
住友商事ケミカル株式会社535,0002.48%
ゼリア新薬工業株式会社483,0002.23%
あすか製薬株式会社366,0001.69%
サンヨーファイン株式会社306,0001.42%
喜美運送株式会社304,0001.41%
株式会社山口薬品商会303,0001.40%

Get this as JSON

GET /v1/companies/4531
GET /v1/companies/4531/financials
GET /v1/companies/4531/details
GET /v1/companies/4531/segments
GET /v1/companies/4531/voting
GET /v1/companies/4531/tender-offers
GET /v1/companies/4531/indicators
GET /v1/companies/4531/earnings-releases
GET /v1/events?ticker=4531
GET /v1/companies/4531/trades         
GET /v1/companies/4531/cross-holdings 
GET /v1/companies/4531/brief

Plans from $9 a month · Documentation